
Loading, please wait...

Loading, please wait...

This cross-sectional study compared cardiometabolic risk factors in obese and non-obese patients with non-alcoholic fatty liver disease (NAFLD). It also explored the relationship between adiposity and NAFLD severity. A total of 452 patients were recruited. Metabolic syndrome risk was substantially higher in overweight and obese NAFLD patients compared to those with normal weight. Further, increase in BMI increase the risk of MS in patients

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This cross-sectional study compared cardiometabolic risk factors in obese and non-obese patients with non-alcoholic fatty liver disease (NAFLD). It also explored the relationship between adiposity and NAFLD severity. A total of 452 patients were recruited. Metabolic syndrome risk was substantially higher in overweight and obese NAFLD patients compared to those with normal weight. Further, increase in BMI increase the risk of MS in patients
2 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today